Top Markets
#1 QuantixAI QuantixAI +52.46%
#2 MowCat MowCat +27.53%
#3 Prom Prom +20.28%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +20.21%
#5 Tutorial Tutorial +18.49%
#6 Versatize Coin Versatize Coin +16.67%
#7 StonkBroker StonkBroker +12.69%
#8 Wrapped NXM Wrapped NXM +11.40%
#9 Pons Pons +10.52%
#10 Nesa Nesa +10.02%
Coin of the day
QuantixAI QuantixAI
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.

ZIOPHARM Oncology, Inc.

ZIOP
Classifica tra le azioni #20772
ZIOPHARM Oncology, Inc. is a clinical-stage biopharmaceutical firm dedicated to... ZIOPHARM Oncology, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing and commercializing innovative immuno-oncology treatments for cancer patients. The company leverages its proprietary Sleeping Beauty platform, which employs non-viral genetic engineering to modify T-cells outside the body using a transposon/transposase system for subsequent infusion. Additionally, ZIOPHARM is advancing its Controlled IL-12 technology, designed to precisely regulate the expression of interleukin-12 (IL-12), a key immune system regulator, to direct the patient's immune response against cancer cells. Its pipeline features several promising therapeutic candidates, including T-cell receptor (TCR) plus T-cell therapies aimed at solid tumors, chimeric antigen receptor (CAR) T-cell therapies specifically targeting CD19 for hematologic malignancies, and Ad-RTS-hIL-12 combined with veledimex, a gene delivery system for controlled IL-12 production under investigation for treating recurrent adult glioblastoma multiforme. ZIOPHARM maintains strategic collaborations, including a licensing agreement with PGEN Therapeutics, Inc., and research and development agreements, alongside patent licensing, with institutions such as The University of Texas MD Anderson Cancer Center and the National Cancer Institute. The company's headquarters are located in Boston, Massachusetts.
Prezzo delle azioni
$0.8657
Ultima sincronizzazione: 2022-01-26
Capitalizzazione di mercato
$122.22M
Variazione (1 giorno)
-0.88%
Variazione (1 anno)
0.00%
Paese
US
Scambia ZIOPHARM Oncology, Inc. (ZIOP)

Categoria

Healthcare
Il prezzo ZIOP con la capitalizzazione del mercato della B
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
ZIOP
$0.8657
Capitalizzazione di mercato di ZIOPHARM Oncology, Inc.(ZIOP)
Capitalizzazione di mercato: $122.22M
A partire dal August 2026, ZIOPHARM Oncology, Inc. ha una capitalizzazione di mercato pari a $122.22M. Questo rende ZIOPHARM Oncology, Inc. la 20772nd azienda più preziosa al mondo per capitalizzazione di mercato secondo i nostri dati. La capitalizzazione di mercato è il valore totale delle azioni in circolazione di una società quotata e viene comunemente utilizzata per misurarne il valore.
Storia della capitalizzazione di mercato di ZIOPHARM Oncology, Inc. dal 2006 al 2026
ZIOP in paragone con la classifica dei più popolari stocks
Il prezzo per ZIOP Attivo B Capitalizzazione del mercato a B Risultati
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
$36,911.68 $122.22M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.211T +4,263,695.77%
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
$32,204.21 $122.22M
Apple Inc. Apple Inc.
AAPL
$4.547T +3,719,919.96%
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
$29,482.46 $122.22M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +3,405,521.01%
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
$25,447.43 $122.22M
Microsoft Corporation Microsoft Corporation
MSFT
$3.593T +2,939,420.54%
ZIOPHARM Oncology, Inc. ZIOPHARM Oncology, Inc.
$19,781.55 $122.22M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.793T +2,284,935.02%